Sage Journals: Discover world-class research

Abstract

ATP-sensitive potassium channels (KATP) may mediate a potential neuroprotective role in Alzheimer’s disease (AD). Given that exposure to Aβ1-42 in cultured primary cholinergic neurons for 72 h significantly upregulates the expression of KATP subunits Kir6.2/SUR1, we aim to study the underlying signal transduction mechanisms that are involved in Aβ_1–42-induced upregulation of KATP subunits Kir6.2/SUR1. In the present study, we first identified the primary cultured rat cortical and hippocampal neurons using immunocytochemistry. 0.5 μM NF-κB inhibitor SN-50, 2 μM p38MAPK inhibitor SB203580 or 2 μM PKC inhibitor Chelerythrine chloride (CTC) were then added in three separate groups, followed by 2 μM Aβ_1–42 30 min later in all 3 groups. Western Blot was performed 72 h later to detect the expression of KATP subunits Kir6.2/SUR1. We found that Aβ_1–42 significantly increased the level of KATP subunits Kir6.2/SUR1 expression at 72 h when compared with the control group (p < 0.05). However, when compared with the Aβ_1–42 group, the level of KATP subunits Kir6.2/SUR1 expression at 72 h significantly decreased in the SN50 + Aβ_1–42 group, SB203580 + Aβ_1–42 group, and the CTC + Aβ_1–42 group (p < 0.05). Our findings suggest that the NF-κB, p38 MAPK, and PKC signal pathways are partially involved in the upregulation of KATP subunits Kir6.2/SUR1 expression induced by Aβ_1–42 cytotoxicity in neurons, which supports a potential theoretical basis of targeting these signal pathways in the treatment of AD.

Keywords

Kir6.2/SUR1 NF-κB p38 MAPK PKC

Introduction

Alzheimer’s disease (AD) is the most common neurodegenerative disease in elderly people and is characterized by hallmark pathological amyloid plaques (Aβ).¹ Considerable evidences show that Aβ could lead to membrane depolarization, mitochondrial dysfunction, and oxidative stress, which could further stimulate the generation and accumulation of Aβ.^2,3 Based on these findings, mitochondrial ATP-sensitive potassium channels (KATP) openers activate potassium channels and have been shown to protect cultured neurons against toxicity induced by Aβ.⁴

KATP channels are widely distributed in different brain regions. The different subunits composition within KATP channels determines the brain regions’ susceptibility to hypoxia, oxidative stress, toxicity, and blood glucose metabolism.⁵ In this regard, previous studies have demonstrated that KATP channels with the Kir6.2/SUR1 subunit were upregulated by Aβ_1–42 and ATP.^4,6 However, the underlying pathophysiology remains unclear. Given that signaling pathways are implicated in the pathogenesis of AD, further studies focusing on the role of Aβ_1–42 in upregulating the signal transduction of KATP channels with the Kir6.2/SUR1 subunit will be paramount as further insight in the signaling transduction pathway may unravel a potential therapeutic target in AD.⁷

NF-κB, p38 MAPK and protein kinase C (PKC) signaling pathways have been linked to AD pathophysiology. The NF-κB signaling pathway is shown to be upregulated in AD,⁸ while analysis of postmortem AD tissues shows an increase level of p38 MAPK phosphorylation associated with Aβ plaques and neurofibrillay tangles (NFTs).^9,10 In addition, oligomeric Aβ can also disrupt the PKC signaling pathway.¹¹

In the present study, we aim to investigate the role of NF-κB, p38 MAPK, and PKC signaling pathways in the upregulation of KATP subunits Kir6.2/SUR1 expression by Aβ_1–42 in primary cultured rat cortical and hippocampal neurons.

Materials and methods

Ethics statement

The rats were housed at the Institutional Animal Care and Use Committee (IACUC), and the Ethics Committee of Shandong Provincial Qianfoshan Hospital approved the study. Wistar rats (birth within 24 h) were housed under controlled temperature (21°C) and light conditions (12-h light/dark cycle) with free access to water and standard diet.

Reagents

Sources of the reagents used in this study were as follow: Poly-l-lysine, Aβ_1–42, cytarabine, SN50, SB203580, chelerythrine chloride (CTC; Sigma, St. Louis, MO, USA); Neurobasal medium, fetal bovine serum (Gibco-BRL, USA); B27-supplement (Invitrogen, California, USA); goat anti-ChAT, rabbit anti-kir6.2, rabbit anti-SUR1, and GAPDH antibodies (Santa Cruz, California, USA); and the ECL light-emitting liquid (Millipore, Billerica, MA, USA).

Cell cultures

Disinfection of the Wistar rats was performed under sterile conditions using 75% ethanol. The cortex and hippocampus were removed and isolated from brains on ice while the meninges were removed by micro-tweezers under a microscope. Using D-hanks cleaning, the brain tissues were cut into pieces and digested for 10 min using 0.125% trypsin. Subsequently, digestion was terminated by Dulbecco’s Modified Eagle Medium (DMEM) (containing 10% fetal bovine serum), filtered (300 mesh), centrifuged (1000 r/min, 5 min), dispersed and mixed by DMEM. The cell suspension was seeded in 60 mm petri dishes (poly-l-lysine pre-coated), cultured (incubator, 37°C, 95% air and 5% CO₂), and after 24 h, replaced with serum-free medium (98% Neurobasal medium + 2% B27 + 1% the two antibiotics). The density of the cells was 3.0 × 10⁶ cells/mL. The cells were treated with cytarabine (5 μmol/L) and cultured for 3–5 days to inhibit the proliferation of gliocyte.

Identification of cholinergic neurons by immunocytochemistry

Choline acetyl transferase (Choactase, ChAT) is a sulfur-based protein with a molecular weight of 65 kDa. ChAT is a presynaptic choline synthesis enzyme which can accurately determine the cholinergic neurons with ChAT antibody as a marker. In this study, cells were plated in glass coverslips and pre-coated with poly-l-lysine. The cells were grown for 7 days in proliferation growth medium, formaldehyde fixed (4% paraformaldehyde, 4°C, 30 min), and washed with PBS (3 × 5 min). Goat anti-ChAT (1:100) was applied overnight (4°C), washed with PBS, biotinylated secondary IgG (1:200) applied for 1 h, room temperature for 30 min, and washed with PBS. The cells were dripped with SABC for 20 min, washed with PBS four times and visualized with DAB for 5 min, stained with hematoxylin. The results were then observed under a light microscope (IM50, Leica, German), and 10 random 20 × 20 fields were observed under the microscope. The cytoplasm of ChAT positive neurons was stained brown (Figure 1).

Figure 1.

Identification of cholinergic neurons by choline acetyl transferase immunocytochemistry (20 × 20). Scale bar = 20 μM.

Experimental treatments

Aβ_1–42 (0.1 mg) was dissolved in dimethylsulfoxide (DMSO) with a concentration of 0.5 mol/L and diluted with PBS (pH 7.4), incubated (37°C, 72 h), and stored at 4°C. Stocks were diluted in serum-free medium prior to experiments and the final concentration of DMSO in cell cultures did not exceed 0.1% as DMSO in this concentration will not have harmful effects to the cells. The cells were then randomly divided into four groups: the control group, the Aβ_1–42 group, the Aβ_1–42 + SN50/SB203580/CTC group, and the SN50/SB203580/CTC group and cultured for 7 days. The control group was treated with equal volume PBS and culture medium; the Aβ_1–42 group was treated with Aβ_1–42 (2 μM)⁴; Aβ_1–42 + SN50/SB203580/CTC group was treated with SN50(0.5 μM)/SB203580(2 μM)/CTC(2 μM), followed by the addition of Aβ_1–42 (2 μM) 30 min later; SN50/SB203580/CTC group was treated with SN50(0.5 μM)/SB203580 (2 μM)/CTC(2 μM), respectively. Western blot analysis was then carried out in all four groups after 72 h.

Western blot analysis

Cells were collected, washed in ice-cold phosphate buffered saline, and lysed in ice in 250 μL lysis buffer (50 mmol/L Tris-HCl pH 8.0, 150 mmol/L NaCl, 0.02% sodium vandate, 0.1% SDS, 0.5% deoxycholic acid, 100 μg/mL PMSF, 0.2 μg/mL leupeptin, 1% NP-40) per dish. After incubation in ice for 20 min, cell lysates were centrifuged (10,000 × g for 10 min at 4°C) and the protein concentrations in the extracts were determined by bicinchoninic acid (BCA) Protein Assay Kit (Pierce, Rockford, Illinois, USA). Forty micrograms protein samples undergone sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene fluoride (PVDF) membrane, blocked with 5% skim milk for 1 h, and closed overnight with primary antibody (rabbit anti-rat Kir6.2 polyclonal antibody (1:500) or rabbit anti-rat SUR1 (1:500) (4°C, shaker)). The PVDF was washed 3 times in TBST (TBS with 0.05% v/v Tween-20) at room temperature and incubated with horseradish peroxidase-conjugated secondary antibody diluted in TBST (1:3,000) for 1 h at room temperature followed by washing. Signal detection was performed with an enhanced chemiluminiscence kit and GAPDH as an internal reference. Analysis of the integral value of the optical density was then performed using an NIH image (1.34) analysis software.

Statistical analysis

Quantitative analyses of the Western blots were performed with the Lecca Qwin Image program by calculating the relative density of the immunoreactive bands after acquisition of the blot image with a Nikon CCD video camera (Nikon Instruments Co, Ltd, Japan) module. Results were expressed as means ± standard deviation. The statistical analyses were performed using one-way analysis of variance, followed by a two-tailed student’s t test. Multiple comparison test was performed where appropriate. Statistical analysis was performed by using the SAS, version 9.4 software (SAS Institute Inc.). A value of p < 0.05 was considered significant.

Results

The effect of NF-κB inhibitor SN50 on the subunit SUR1 of neural KATP expression is induced by Aβ_1–42

Western blot results showed that Aβ_1–42 significantly increased the level of KATP subunit SUR1 expression at 72 h compared with the control group (p < 0.05). Compared with Aβ_1–42 group, the level of KATP subunit SUR1 expression decreased significantly in both SN50 + Aβ_1–42 and SN50 groups (p < 0.01). When compared with the control group, Aβ_1–42 group, and SN50+Aβ_1–42 group separately, the level of KATP subunit SUR1 expression decreased significantly in the SN50 group (p < 0.01; Figure 2).

Figure 2.

(a) Western blot showed that the effect of control group, Aβ_1–42 group, SN50 + Aβ_1–42 group, and SN-50 group on the subunit SUR1 expression in primary cultured neurons for 72 h. (b) Protein levels were determined by densitometric analysis of Western blots and were normalized to GAPDH; values are means ± SD of three independent experiments. *p < 0.05 or **p < 0.01 denote Aβ_1–42 or SN50 versus control; ⁺⁺p < 0.01denotes Aβ_1–42 + SN50 or SN50 versus Aβ_1–42; ^##p < 0.01 denotes SN50 versus SN50 + Aβ_1–42 group, separately (n = 3).

The effect of NF-κB inhibitor SN50 on the subunit Kir6.2 of neural KATP expression is induced by Aβ_1–42

Western blot results showed that Aβ_1–42 significantly increased the level of KATP subunit Kir6.2 expression at 72 h compared with the control group (p < 0.05). Compared with Aβ_1–42 group, the level of KATP subunit Kir6.2 expression decreased significantly in both SN50 + Aβ_1–42 and SN50 groups (p < 0.01 and p < 0.05). When compared with both SN50 + Aβ_1–42 and control groups, there is no difference in the level of KATP subunit Kir6.2 expression in the SN50 group (p > 0.05; Figure 3).

Figure 3.

(a) Western blot showed that the effect of control group, Aβ_1–42 group, SN50 + Aβ_1–42 group, and SN-50 group on the subunit Kir6.2 expression in primary cultured neurons for 72 h. (b) Protein levels were determined by densitometric analysis of Western blots and were normalized to GAPDH; values are means ± SD of three independent experiments. *p < 0.05 denotes Aβ_1–42 group versus control; ⁺p < 0.05 or ⁺⁺p < 0.01 denote SN50 or Aβ_1–42 + SN50 group versus Aβ_1–42 group, separately (n = 3).

The effect of p38 MAPK inhibitor SB203580 on the subunit SUR1 of neural KATP expression is induced by Aβ_1–42

Western blot results showed that Aβ_1–42 significantly increased the level of KATP subunit SUR1 expression at 72 h compared with the control group (p < 0.05). Compared with Aβ_1–42 group, the level of KATP subunit SUR1 expression decreased significantly in both SB203580 + Aβ_1–42 and SB203580 groups (p < 0.05). When compared with the control and SB203580 + Aβ_1–42 group separately, there is no difference in the level of KATP subunit SUR1 expression in the SB203580 group (p > 0.05; Figure 4).

Figure 4.

(a) Western blot showed that the effect of control group, Aβ_1–42 group, SB203580 + Aβ_1–42 group, and SB203580 group on the subunit SUR1 expression in primary cultured neurons for 72 h. (b) Protein levels were determined by densitometric analysis of Western blots and were normalized to GAPDH; values are means ± SD of three independent experiments. *p < 0.05 denotes Aβ_1–42 group versus control; ⁺p < 0.05 denotes Aβ_1–42 + SB203580 group or SB203580 group versus Aβ_1–42 group, separately (n = 3).

The effect of p38 MAPK inhibitor SB203580 on the subunit Kir6.2 of neural KATP expression is induced by Aβ_1–42

Western blot results showed that Aβ_1–42 significantly increased the level of KATP subunit Kir6.2 expression at 72 h compared with the control group (p < 0.05). Compared with Aβ_1–42 group, the level of KATP subunit Kir6.2 expression decreased significantly in both SB203580 + Aβ_1–42 and SB203580 groups (p < 0.05 and p < 0.01, respectively). When compared with both control group and SB203580 + Aβ_1–42 group separately, the level of KATP subunit Kir6.2 expression decreased significantly in the SB203580 group (p < 0.05; Figure 5).

Figure 5.

(a) Western blot showed that the effect of control group, Aβ_1–42 group, SB203580 + Aβ_1–42 group, and SB203580 group on the subunit Kir6.2 expression in primary cultured neurons for 72 h. (b) Protein levels were determined by densitometric analysis of Western blots and were normalized to GAPDH; values are means ± SD of three independent experiments. *p < 0.05 denotes Aβ_1–42 group or SB203580 group versus Control; ⁺p < 0.05 or ⁺⁺p < 0.01 denote Aβ_1–42 + SB203580 group or SB203580 group versus Aβ_1–42 group, ^#p < 0.05 denotes SB203580 group versus Aβ_1–42 + SB203580 group, separately (n = 3).

The effect of PKC inhibitor CTC on the subunit SUR1 of neural KATP expression is induced by Aβ_1–42

Western blot results showed that Aβ_1–42 significantly increased the level of KATP subunit SUR1 expression at 72 h compared with the control group (p < 0.05). Compared with Aβ_1–42 group, the level of KATP subunit SUR1 expression decreased significantly in both CTC + Aβ_1–42 and CTC groups (p < 0.05 and p < 0.01, respectively). When compared with both control and CTC + Aβ_1–42 groups, the level of KATP subunit SUR1 expression decreased significantly in the CTC group (p < 0.05; Figure 6).

Figure 6.

(a) Western blot showed that the effect of control group, Aβ_1–42 group, CTC + Aβ_1–42 group, and CTC group on the subunit SUR1 expression in primary cultured neurons for 72 h. (b) Protein levels were determined by densitometric analysis of Western blots and were normalized to GAPDH; values are means ± SD of three independent experiments. *p < 0.05 denotes Aβ_1–42 or CTC versus control; ⁺p < 0.05 or ⁺⁺p < 0.01 denotes Aβ_1–42 + CTC or CTC versus Aβ_1–42;^#p < 0.05 denotes CTC versus Aβ_1–42 + CTC, separately (n = 3).

The effect of PKC inhibitor CTC on the subunit Kir6.2 of neural KATP expression is induced by Aβ_1–42

Western blot results showed that Aβ_1–42 significantly increased level of KATP subunit Kir6.2 expression at 72 h compared with the control group (p < 0.05). Compared with Aβ_1–42 group, the level of KATP subunit Kir6.2 expression decreased significantly in both CTC + Aβ_1–42 and CTC groups (p < 0.01). Compared with CTC + Aβ_1–42 group, the level of KATP subunit Kir6.2 expression increased significantly in the CTC group (p < 0.05). When compared with the control group, there is no difference in the level of KATP subunit Kir6.2 expression in the CTC group (p > 0.05; Figure 7).

Figure 7.

(a) Western blot showed that the effect of control group, Aβ_1–42 group, CTC + Aβ_1–42 group, and CTC group on the subunit Kir6.2 expression in primary cultured neurons for 72 h. (B) Protein levels were determined by densitometric analysis of Western blots and were normalized to GAPDH; values are means ± SD of three independent experiments. *p < 0.05 denotes Aβ_1–42 group or Aβ_1–42 + CTC group versus control; ⁺⁺p < 0.01 denotes CTC or Aβ_1–42 +CTC versus Aβ_1–42 group; ^#p < 0.05 denotes CTC group versus Aβ_1–42 + CTC group, separately (n = 3).

Discussion

Aβ-induced neurotoxicity plays a key role in the pathogenesis of AD.¹² Evidence suggests that excessive oxidative stress and free radicals toxic effects constitute one of the mechanisms of Aβ-induced neurotoxicity leading to the development of AD.¹³ In a healthy individual, the production and elimination of free radicals are normal physiological processes which maintain a dynamic equilibrium. However, when excessive oxidative stress is induced by Aβ, this may eventually break this balance, leading to cell death mainly via the apoptotic pathway.¹⁴ Aβ causes modification of the lipid membrane and protein oxidation, increases reactive oxygen species (ROS), and decreases mitochondrial function and ATPase activity.¹⁵ These lead to energy metabolism and mitochondrial membrane potential dysfunctions and decreased cell viability. On the other hand, studies also show that cyclosporin A, erythropoietin, and ATP-sensitive potassium channel opener diazoxide may exert protective effects on Aβ-induced neurotoxicity.^16,17

KATP is a multi-protein complex composed of inward rectifier potassium channel with two different subunits: Kir6.1/Kir6.2 and SUR1/SUR2 and the formation of heterogeneous octamer to 1:1. KATP plays an important role within the plasma membrane by reducing the excitability of cardiac cells, neurons, and other excitable cells. In the mitochondria, KATP (Mito-KATP) is involved in the regulation of the mitochondrial membrane potential (ΔΨm) and regulates the generation of ATP and ROS.¹⁸ Our previous study in cultured primary rat cholinergic neurons showed that exposure to Aβ_1–42 for varying durations could induce differential increase of KATP subunits expression while at the same time inhibit KATP channel ion currents. Importantly, preactivation of mitoK_ATP by diazoxide could reverse above changes.¹⁹ In addition, exposure to Aβ_1–42 for 24 h did not affect the expression of KATP subunits Kir6.2/SUR1.^5,20

Our results showed that exposure to 2 μM Aβ_1–42 for 72 h significantly increased the expression of KATP subunits Kir6.2 and SUR1 in primary cultured neurons compared with the control group. One possible mechanism is the persistence of oxidative stress induced by Aβ_1–42 which could lead to mitochondrial dysfunction, cell metabolism disorder, and decreased intracellular ATP level. Given that the KATP subunits Kir6.2/SUR1 are especially sensitive to oxidative stress,⁶ the expression of Kir6.2/SUR1 subunits may significantly increase as the levels of intracellular ATP decrease. In addition, Aβ_1–42 may induce neuroinflammation by activating glial cells which further stimulate the expression of Kir6.2/SUR1 via nonspecific signal pathways. The increased activation and protein expression of the Kir6.2/SUR1 subunit may be a physiological response to maintain normal cell membrane potential and spontaneous electrical activity to prevent Aβ_1–42 cytotoxicity.

NF-κB is a nuclear transcription factor in a variety of cells within the human body. Activated NF-κB plays a key role in the pathophysiology of diseases by regulating gene expression, immune response, and apoptosis signaling when translocated to the nucleus.²¹ Studies have reported that Aβ activates NF-κB expression in the neurons.^8,22 Furthermore, Mattson et al. showed the anti-apoptotic mechanism of NF-κB by inducing the production of manganese superoxide dismutase (Mn-SOD) which inhibited the formation of peroxynitrite and membrane lipid peroxidation in AD.²³

In this study, exposure to Aβ_1–42 for 72 h significantly increased the expression of KATP subunits Kir6.2/SUR1 when compared with the control group. We demonstrated this using SN50, a NF-κB inhibitor with 41 amino acid residues of the polypeptide. SN50 contains the p50 nuclear localization sequence that penetrates the cell and specifically blocks the shift of NF-κB from the cytoplasm to the nucleus and hence inhibits NF-κB DNA binding activity. In the SN50 + Aβ_1–42 group, the levels of KATP subunits Kir6.2/SUR1 expression significantly decreased compared with the Aβ_1–42 group, indicating that SN50 significantly decreased Aβ_1–42-induced Kir6.2/SUR1 protein expression level. One possible mechanism is that SN50 interferes with NF-κB by inhibiting NF-κB nuclear translocation, thereby affecting the subunits Kir6.2/SUR1 mRNA transcription expression induced by Aβ_1–42. NF-κB signal pathway is also involved in the increase in expression of KATP Kir6.2/SUR1 subunits induced by Aβ in neurons.

However, the KATP subunit SUR1 expression in SN50 group significantly decreased when compared with the control group, Aβ_1–42 group and SN50 + Aβ_1–42 group. This finding suggests that the inhibitory effect of SN50 on the increased expression of KATP subunit SUR1 induced by Aβ_1–42 is nonspecific. Compared with both SN50 + Aβ_1–42 and control groups, there is no difference in the expression of the KATP subunit Kir6.2 in the SN50 group. This suggests that the inhibitory effect of SN50 on the increased expression of subunit Kir6.2 induced by Aβ_1–42 is specific. Therefore, we conclude that the NF-κB signal pathway is partially involved in the increased expression of the KATP subunits Kir6.2/SUR1 induced by Aβ in neurons.

The MAPKs are a class of serine/threonine kinases that responds to extracellular signals such as growth factors, mitogens, and cellular stress that mediates proliferation, differentiation, and cell survival in mammalian cells. The p38 MAPK is a member of MAPKs within mammalian cells.²⁴ p38 MAPK is located in the cytoplasm during normal physiological conditions and can be quickly transferred to the nucleus when activated to trigger transcription factors, gene expression, and cell-delayed death.²⁵ Pro-inflammatory cytokines and stress stimuli can activate p38 MAPK.^26,27 It is shown that Aβ is able to stimulate glial cell cultures and activate p38 MAPK and MK2, hence upregulating the production of inflammatory cytokines such as IL-1β and TNF-α.^28
–30 In this regard, an oligomeric Aβ synthetic peptide strongly stimulates p38 MAPK kinase.³¹ Due to overstimulation of the Aβ-stimulated glial cells, an increased release of inflammatory mediators lead to neuroinflammatory and neurotoxic effects on surrounding neurons³² and the loss of neurons observed in neurodegenerative diseases. In human AD brain and transgenic mouse models, activated p38α MAPK has been reported to localize in areas where NFTs, amyloid plaques, and glial cells are present under pathophysiological conditions.⁹

The selective p38 MAPK inhibitor SB203580 plays a major role in T160 of the ATP-binding active site,³³ by causing the p38 MAPK to lose a kinase activity. As a result, the p38 MAPK is unable to bind with ATP. It is also known that the activities of p38α and p38β can be inhibited readily by SB203580 by binding to the ATP binding pocket of p38 MAPK. While this inhibits its ability to undergo autophosphorylation, the capacity of p38 MAPK to be phosphorylated by upstream MAPKK is not affected. Taking advantage of this chemical property, SB203580 has been used to identify p38 MAPK autophosphorylation in cultured cells in several prior published studies.^34,35 In the SB203580 + Aβ_1–42 group, the expression of the KATP subunits Kir6.2/SUR1 significantly decreased compared with the Aβ_1–42 group, which indicates that SB203580 significantly decreased Aβ_1–42-induced Kir6.2/SUR1 protein expression level. The possible mechanism is the proliferation of surrounding glial cell activated by Aβ_1–42, which releases inflammatory products and activation of p38 MAPK. The p38 MAPK is then transferred quickly to the nucleus, activating the transcription factor, and causing the increase in mRNA expression of the KATP subunits Kir6.2/SUR1. This finding suggests that activated p38 MAPK not only has a neuroinflammatory effect that leads to the increase of Kir6.2/SUR1 mRNA expression but also has a neurotoxic effect on surrounding neurons. However, SB203580 occupies the ATP binding sites that result in p38 MAPK losing its ability to bind with ATP, thereby not only weakening the Aβ cytotoxicity action but also significantly decreasing Aβ_1–42-induced Kir6.2/SUR1 protein expression level. Therefore, the p38 MAPK signal pathway is also involved in the increased expression of KATP subunits Kir6.2/SUR1 induced by Aβ_1–42 cytotoxicity in neurons.

In the SB203580 group, the expression of the KATP subunits Kir6.2 significantly decreased compared with the control, Aβ_1–42, and SB203580 + Aβ_1–42 groups separately, indicating that the inhibitory effect of SB203580 on the increased expression of subunit Kir6.2 induced by Aβ_1–42 is nonspecific. However, when compared with both control and SB203580 + Aβ_1–42 groups, there is no difference in the expression of the KATP subunit SUR1 in the SB203580 group, indicating that the inhibitory effect of SB203580 on the increased expression of KATP subunit SUR1 induced by Aβ_1–42 is specific. Therefore, we conclude that p38 MAPK signal pathway is partially involved in the increased expression of the KATP subunits Kir6.2/SUR1 induced by Aβ in neurons.

PKC is a phospholipid-dependent serine/threonine kinase and consists of at least 12 isoenzymes.³⁶ PKC is distributed in the cell membrane and cytoplasm³⁷ and exists in an inactive form in the cytoplasm when in the resting state. PKC will shift to the cell membrane when activated during stress. Numerous studies have suggested that phorbol 12-myristate 13-acetate is a nonspecific PKC activator that is capable of decreasing the level of Aβ in neurons.³⁸ The α-secretases are potently regulated by PKC, particularly the α- and ε-isozymes.³⁹ In addition, oligomeric Aβ treatment can activate cytosolic PKC in NT2 within 24 h.¹¹ PKC activation also has a crucial role in learning and memory enhancement. Conversely, inhibition of PKC consistently abolishes learning and memory retention. The strategy of PKC-mediated activation of α-secretases, therefore, has the advantage of three parallel beneficial consequences in AD therapy: increasing production of sAPPα, reducing Aβ, and enhancing memory via PKC-mediated phosphorylation of downstream substrates.⁴⁰

In this experiment, the cortical and hippocampal cholinergic neurons were processed by a PKC inhibitor CTC, and the expression of KATP subunits Kir6.2/SUR1 in the CTC + Aβ_1–42 group significantly decreased compared with Aβ_1–42 group. This finding indicates that CTC significantly decreased Aβ_1–42-induced Kir6.2/SUR1 protein expression level. The possible mechanism is that the activation of the PKC from the cytoplasm to the cell membrane promotes a variety of protein phosphorylations, including serine or threonine residues of ion channel protein. This changes the KATP channel protein conformation and gating kinetics that increases the expression of the KATP subunits Kir6.2/SUR1. The PKC inhibitor CTC inhibits a series of protein phosphorylation action, thereby decreasing the expression of KATP channel protein to regulate the opening and closing of ion channels. Therefore, the PKC signal pathway is also involved in the increased expression of KATP subunits Kir6.2/SUR1 in neurons.

Compared with both control and CTC + Aβ_1–42 groups, the expression of KATP subunit SUR1 significantly decreased in the CTC group, indicating that the inhibitory effect of CTC on the increased expression of KATP subunit SUR1 induced by Aβ_1–42 is nonspecific. But when compared with the control group, there is no difference in the expression of the KATP subunit Kir6.2 in the CTC group. This indicates that the inhibitory effect of CTC on the increased expression of KATP subunit Kir6.2 induced by Aβ_1–42 is specific. It is concluded that PKC signal pathway is also partially involved in the increased expression of the KATP subunit Kir6.2/SUR1 induced by Aβ_1–42 cytotoxicity in neurons.

KATP may also mediate a potential neuroprotective role in AD. Our previous study showed that the exposure of primary cultured cholinergic neurons to Aβ_1–42 for 72 h leads to a differential increase in the expression of KATP subunits. In this study, the NF-κB, p38 MAPK, and PKC signal pathways are partially involved in the increased expression of the KATP subunits Kir6.2/SUR1 induced by Aβ_1–42 cytotoxicity in neurons, as inhibiting the above signal pathways reduces the expression of KATP subunits Kir6.2/SUR1 in neurons.

Conclusions

Our findings indicate that the signal pathways of NF-κB, p38 MAPK, and PKC play a key role in increasing the levels of Aβ_1–42-induced Kir6.2/SUR1 protein expression. We postulate that the possible underlying causes include neuroinflammation, gene transcription, and protein phosphorylation. These findings support a potential theoretical basis of targeting these signal pathways in the treatment of AD.

Footnotes

Authors’ note

G Ma is now affiliated with East Hospital, Tongji University School of Medicine, People’s Republic of China.

Authors’ contribution

Yanju Li and Maowen Ba contributed equally to this work.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the General Program of the National Natural Science Foundation of the People’s Republic of China (project proposal no. 30870874 and 81571234) and the Young Scholars General Program of the National Natural Science Foundation of the People’s Republic of China (project proposal no. 30600202).

ORCID iD

G Ma

References

Kawasumi

Hashimoto

Chiba

. Molecular Mechanisms for neuronal cell death by Alzheimer’s amyloid precursor protein relevant insults. Neurosignals 2002; 11: 236–250.

Watson

Castaño

Kokjohn

. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer’s disease. Neurol Res 2005; 27: 869–881.

Carrotta

Di Carlo

Manno

. Toxicity of recombinant beta-amyloid prefibrillar oligomers on the morphogenesis of the sea urchin Paracentrotus lividus. FASEB J 2006; 20: 1916–1917.

Zhang

. Effects of Aβ_1-42 on the subunits of KATP expression in cultured primary rat basal forebrain neurons. Neurochem Res 2008; 33: 1419–1424.

Yamada

Kane

Behfar

. Protection conferred by myocardial ATP-sensitive K⁺ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J Physiol 2006; 577: 1053–1065.

Yamada

Isomoto

Matsumoto

. Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K⁺ channel. J Physiol 1997; 499: 715–720.

Sattiraju

Reyes

Kane

. K(ATP) channel pharmacogenomics: from bench to bedside. Clin Pharmacol Ther 2008; 83: 354–357.

Kaltschmidt

Uherek

Volk

. Transcription factor NF-κB is activated in primary neurons by amyloid peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci 1997; 94: 2642–2647.

Ferrer

. Stress kinases involved in tau phosphorylation in Alzheimer’s disease, tauopathies and APP transgenic mice. Neurotox Res 2004; 6: 469–475.

10.

Zhu

Rottkamp

Hartzler

. Activation of MKK6, an upstream activator of p38, in Alzheimer’s disease. J Neurochem 2001; 79: 311–318.

11.

Kim

Chae

. Soluble oligomeric Aβ disrupts the protein kinase C signaling pathway. Neuroreport 2004; 15: 503–507.

12.

Selkoe

. Clearing the brain’s amyloid cobwebs. Neuron 2001; 32: 177–180.

13.

Liu

Yin

Zheng

. Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway. Neurochem Int 2007; 51: 361–369.

14.

Patel

Brewer

. Age-related differences in NF-κB translocation and Bcl-2/Bax ratio caused by TNFα and Abeta42 promote survival in middle-age neurons and death in old neurons. Exp Neurol 2008; 213: 93–100.

15.

Tickler

Wade

Separovic

. The role of Aβ peptides in Alzheimer’s disease. Protein Pept Lett 2005; 12: 513–519.

16.

Zeng

Wang

Jiang

. Diazoxide and cyclosporin A protect primary cholinergic neurons against beta-amyloid (1-42)-induced cytotoxicity. Neurol Res 2013; 35: 529–536.

17.

Zhi-Kun

Hong-Qi

Zhi-Quan

. Erythropoietin prevents PC12 cells from beta-amyloid-induced apoptosis via PI3K/Akt pathway. Transl Neurodegener 2012; 1: 7.

18.

Liu

Slevin

. Involvement of mitochondrial K⁺ release and cellular efflux in ischemic and apoptotic neuronal death. J Neurochem 2003; 86: 966–979.

19.

Tan

. Effects of Aβ1-42 on the current of KATP channels in cultured cholinergic neurons. Neurol Res 2012; 34: 707–713.

20.

Gao

. Diazoxide reverses the enhanced expression of KATP subunits in cholinergic neurons caused by exposure to Aβ1-42. Neurochem Res 2009; 34: 2133–2140.

21.

Elfering

Sarkela

Giulivi

. Biochemistry of mitochondria nitric oxide synthase. J Biol Chem 2002; 277: 38079–38086.

22.

Geng

Zhang

Liu

. Inhibition of miR-128 Abates Aβ-mediated cytotoxicity by targeting PPAR-γ via NF-κB inactivation in primary mouse cortical neurons and neuro2a cells. Yonsei Med J 2018; 59: 1096–1106.

23.

Mattson

Culmsee

. Roles of nuclear factor κB in neuronal survival and plasticity. J Neurochem 2000; 74: 443–456.

24.

Cuadrado

Nebreda

. Mechanisms and functions of p38 MAPK signaling. Biochem J 2010; 429: 403–417.

25.

Barone

Irving

Ray

. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev 2001; 21: 129–145.

26.

Ossum

Lauritsen

Karottki

. Differential role for ERK2 in anoxia-induced activation of transcription and translation of Hsp70 in NIH 3T3 cells. Cell Physiol Biochem 2011; 27: 109–l20.

27.

Shukla

Saxena

Jayamurthy

. Hypoxic preconditioning with cobalt attenuates hypobaric hypoxia-induced oxidative damage in rat lungs. High Alt Med Biol 2009; 10: 57–69.

28.

Munoz

Ralay Ranaivo

Roy

. A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer’s disease mouse model. J Neuroinflammation 2007; 4: 21.

29.

Kim

Smith

Van Eldik

. Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production. Neurobiol Aging 2004; 25: 431–439.

30.

Bachstetter

Xing

de Almeida

. Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ). J Neuroinflammation 2011; 8: 79.

31.

Sondag

Dhawan

Combs

. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J Neuroinflammation 2009; 6: 1–13.

32.

Bodles

Barger

. Secreted β-amyloid precursor protein activates microglia via JNK and p38-MAPK. Neurobiol Aging 2005; 26: 9–16.

33.

Kikuchi

Tenneti

Lipton

. Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cell. J Neurosci 2000; 20: 5037–5044.

34.

Gram

Di Padova

. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38α. Science 2002; 295: 1291–1294.

35.

Miller

Ninomiya-Tsuji

. AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ Res 2005; 97: 872–879.

36.

D’Cruz

Fertig

Filiano

. Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. J Cereb Blood Flow Metab 2002; 22: 843–851.

37.

Bullock

Shan

. PKC isoforms were reduced by lead in the developing rat brain. Int J Dev Neurosci 2005; 23: 53–64.

38.

Dou

. Promising multifunctional anti-Alzheimer’s dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of α-secretase and BACE-1 concurrently. Eur J Pharmacol 2009; 623: 14–21.

39.

Lanni

Mazzucchelli

Porrello

. Differential involvement of protein kinase C alpha and epsilon in the regulated secretion of soluble amyloid precursor protein. Eur J Biochem 2004; 271: 3068–3075.

40.

Alkon

Epstein

Kuzirian

. Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning. Proc Natl Acad Sci 2005; 102: 16432–16437.

Aβ1-42 increases the expression of neural KATP subunits Kir6.2/SUR1 via the NF-κB,p38 MAPK and PKC signal pathways in rat primary cholinergic neurons